Methotrexate as an alternative therapy for chronic calcium pyrophosphate deposition disease: an exploratory analysis.
暂无分享,去创建一个
[1] B. Cronstein,et al. Low-Dose Methotrexate: A Mainstay in the Treatment of Rheumatoid Arthritis , 2005, Pharmacological Reviews.
[2] M. Brown,et al. Genetic studies of chondrocalcinosis , 2005, Current opinion in rheumatology.
[3] N. Dalbeth,et al. Inflammation and tissue damage in crystal deposition diseases , 2005, Current opinion in rheumatology.
[4] H. Cheung. Biologic effects of calcium-containing crystals , 2005, Current opinion in rheumatology.
[5] T. Pincus,et al. Long term safety of methotrexate in routine clinical care: discontinuation is unusual and rarely the result of laboratory abnormalities , 2004, Annals of the rheumatic diseases.
[6] R. Terkeltaub,et al. Inorganic pyrophosphate (PPI) in pathologic calcification of articular cartilage. , 2005, Frontiers in bioscience : a journal and virtual library.
[7] B. Cronstein,et al. Adenosine: an endogenous regulator of innate immunity. , 2004, Trends in immunology.
[8] Hyon K. Choi,et al. A cost effectiveness analysis of treatment options for methotrexate-naive rheumatoid arthritis. , 2002, The Journal of rheumatology.
[9] A. Rubinow,et al. Safety of low dose methotrexate in elderly patients with rheumatoid arthritis , 2000, Postgraduate medical journal.
[10] H. Cheung. Calcium crystal effects on the cells of the joint: implications for pathogenesis of disease. , 2000, Current opinion in rheumatology.
[11] M. Seitz,et al. Molecular and cellular effects of methotrexate. , 1999, Current opinion in rheumatology.
[12] M. Weinblatt,et al. Longterm prospective study of methotrexate in rheumatoid arthritis: conclusion after 132 months of therapy. , 1998, The Journal of rheumatology.
[13] M. Weinblatt,et al. The effects of drug therapy on radiographic progression of rheumatoid arthritis. Results of a 36-week randomized trial comparing methotrexate and auranofin. , 1993, Arthritis and rheumatism.
[14] A. Alvarellos,et al. Colchicine prophylaxis in pseudogout. , 1986, The Journal of rheumatology.
[15] D. Mccarty. Calcium pyrophosphate dihydrate crystal deposition disease: nomenclature and diagnostic criteria. , 1977, Annals of internal medicine.